A detailed history of Flagship Pioneering Inc. transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Flagship Pioneering Inc. holds 12,674,120 shares of FHTX stock, worth $63.6 Million. This represents 20.03% of its overall portfolio holdings.

Number of Shares
12,674,120
Previous 12,674,120 -0.0%
Holding current value
$63.6 Million
Previous $72.9 Million 61.91%
% of portfolio
20.03%
Previous 8.71%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

BUY
$15.12 - $25.88 $192 Million - $328 Million
12,674,120 New
12,674,120 $257 Million

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $209M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Flagship Pioneering Inc. Portfolio

Follow Flagship Pioneering Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flagship Pioneering Inc., based on Form 13F filings with the SEC.

News

Stay updated on Flagship Pioneering Inc. with notifications on news.